Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC-trial in COPD exacerbations
NL-OMON25445Active, not recruiting
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of amoxicillin + clavulanate and prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Duration of exacerbation. Started May 2005; status: active, not recruiting.
02
Drugs
amoxicillin + clavulanateprednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON25445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25445.